Abstract:We have previously shown that chloride channel activities were cell cycle-dependent and were involved in cell proliferation in nasopharyngeal carcinoma cells. In this study, the expression and roles of volume-activated chloride channels in cell growth were investigated in the poorly-differentiated human nasopharyngeal carcinoma cell (CNE-2Z) and its counterpart, the normal human nasopharyngeal epithelial cell (NP69-SV40T). Consistent with growth ability, the background chloride currents recorded under isotonic condition, the volume-activated chloride currents induced by 47% hypotonic challenges and the hyponinicity-induced regulatory volume decrease (RVD) were much larger in CNE-2Z cells than in NP69-SV40T cells, suggesting the up-regulation of expression of volume-activated chloride channels in cancerous cells. This was proved by the up-regulation of ClC-3 proteins, a candidate of volume-activated chloride channels, in the cancerous cells. Functional inhibition of chloride channel activities by the chloride channel blockers, 5-nitro-2-(3-phenylpropylamino)benzoic acid (NPPB) and tamoxifen, and knock-down of ClC-3 expression by specific ClC-3 siRNA attenuated the background currents, suppressed the activation of volume-activated chloride currents, decreased the hyponinicity-induced RVD and inhibited cell growth in the cancerous and normal cells. However, the sensitivities of the cancerous cells were much higher than that of the normal cells. Our data suggest that volume-activated chloride channels play a more important role in control cell proliferation in the cancerous cells than in the normal cells; the growth of cancerous cells is more dependent on the activities of volume-activated chloride channels than that of the normal cells. ClC-3 protein may be considered as a potential tumor marker and therapeutic target for human nasopharyngeal carcinoma

Volume-activated Cl- Current in Migrated Nasopharyngeal Carcinoma Cells.

Blockage of volume-activated chloride channels inhibits migration of nasopharyngeal carcinoma cells.

Cell cycle-dependent expression of volume-activated chloride currents in nasopharyngeal carcinoma cells.

Volume-activated Chloride Currents in Highly Differentiated Nasophyaryngeal Carcinoma CNE-1 Cells

Spontaneous chloride currents in poorly differentiated nasopharyngeal carcinoma cells

Roles of Chloride Channels in the Migration of Nasopharyngeal Carcinoma Cells at Different Stages of the Cell Cycle

Involvement of Regulatory Volume Decrease in the Migration of Nasopharyngeal Carcinoma Cells

Suppression of ClC-3 Channel Expression Reduces Migration of Nasopharyngeal Carcinoma Cells

Functional Expression of Chloride Channels and Their Roles in the Cell Cycle and Cell Proliferation in Highly Differentiated Nasopharyngeal Carcinoma Cells.

Different Properties Between Spontaneous and Volume‐activated Chloride Currents in Human Nasopharyngeal Carcinoma and Its Normal Counterpart Cells

Volume-activated Chloride Channels Contribute to Cell-Cycle-dependent Regulation of HeLa Cell Migration

Differential Expression and Roles of Volume-Activated Chloride Channels in Control of Growth of Normal and Cancerous Nasopharyngeal Epithelial Cells

Roles Of Volume-Activated Cl- Currents And Regulatory Volume Decrease In The Cell Cycle And Proliferation In Nasopharyngeal Carcinoma Cells

Volume-Activated Chloride Currents in Fetal Human Nasopharyngeal Epithelial Cells

Clc-3 is A Main Component of Background Chloride Channels Activated under Isotonic Conditions by Autocrine Atp in Nasopharyngeal Carcinoma Cells

Chloride Currents Activated by Cisplatin in Nasopharyngeal Carcinoma Cells

ClC-3 expression in the cell cycle of nasopharyngeal carcinoma cells.

Cisplatin Activates Volume-Sensitive Like Chloride Channels Via Purinergic Receptor Pathways in Nasopharyngeal Carcinoma Cells.

ClC-3 is a candidate of the channel proteins mediating acid-activated chloride currents in nasopharyngeal carcinoma cells.

ClC-3 Chloride Channels Are Essential for Cell Proliferation and Cell Cycle Progression in Nasopharyngeal Carcinoma Cells.